B+
Bull case
30%
Probability
Target price
$125.00
Analysis reference price unavailable
Analysis 2026-07-21 · RankAlpha Sentiment Codex
ABT
Abbott LaboratoriesBNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Abbott combines a Q2 beat with higher adjusted EPS guidance, diversified second-half growth drivers and potential upside from electrophysiology launches, Nutrition recovery, diagnostics demand and future CGM reimbursement. The deterministic prior is positive, with expected returns of 1.77% over 5 days, 5.05% over 20 days and 10.62% over 120 days.
Posture
Constructive
Lead driver
Sentiment
What changed
1 setup hits (3d) with net bullish as of 2026-09-09.
What can break
Abbott's reported adjusted results exclude specified items and intangible amortization; the SEC filing cautions that non-GAAP measures are not substitutes for GAAP measures [#SEC-8K-2026-07-16].
Momentum
64
Value
54
Sentiment
73
Setup hits (3d)
1 · Net Bullish
AI TargetsBase $115.00 · Bull $125.00 · Bear $92.00Analysis 2026-07-21; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-21 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $120.75
Why
Momentum64 · Δ7d +0.7
Value54 · Δ7d -0.0
Sentiment73 · Δ7d +10.7
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Confirming evidence
- • 1 setup hits (3d) with net bullish as of 2026-09-09.
- • Sentiment remains the lead driver in the composite, 7D delta +10.7.
Contradictions & invalidation
- • Abbott's reported adjusted results exclude specified items and intangible amortization; the SEC filing cautions that non-GAAP measures are not substitutes for GAAP measures [#SEC-8K-2026-07-16].
- • CGM growth has moderated and reimbursement catalysts may arrive later than expected.
- • The market may already reflect the beat and raise.
Catalyst clock
2026-07-31
Post-print momentum fade or execution reset
Lead driver: Sentiment · See AI snapshot
Momentum
64
9% active weight
Current posture
7d trendImproving
Δ7d
+0.7
Δ21d
-18.2
Value
54
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.5
Sentiment
73
62% active weight
Current posture
7d trendImproving
Δ7d
+10.7
Δ21d
+10.7
Why this grade
Composite grade B. Momentum 64.1 / Value 54.4 / Sentiment 73.1
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-07-21. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$115.00
Analysis reference price unavailable
Analysis 2026-07-21 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$92.00
Analysis reference price unavailable
Analysis 2026-07-21 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$190.98B
Beta
0.75
Shares Out
1.73B
P/E (TTM)
15.8
P/S (TTM)
5.02
P/FCF (TTM)
76.53
Rev YoY
+13.0%
EPS YoY
-48.2%
Gross Margin
+52.8%
Op Margin
+16.4%
Net Debt
$5.2B
Current Ratio
1.38
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data